home / stock / zlab / zlab news


ZLAB News and Press, Zai Lab Limited From 06/07/23

Stock Information

Company Name: Zai Lab Limited
Stock Symbol: ZLAB
Market: NASDAQ
Website: zailaboratory.com

Menu

ZLAB ZLAB Quote ZLAB Short ZLAB News ZLAB Articles ZLAB Message Board
Get ZLAB Alerts

News, Short Squeeze, Breakout and More Instantly...

ZLAB - RBLX, VXRT and TRVN among pre-market losers

2023-06-07 08:27:22 ET United Natural Foods ( UNFI ) -24% after Q3 earning release , Mondee Holdings ( MOND ) -24% announces pricing of secondary offering of common stock by selling stockholders. Vaxart ( VXRT ) -23% announces proposed public offe...

ZLAB - Why did NovoCure stock crash today? TTFields data

2023-06-06 21:51:06 ET Shares of NovoCure Limited ( NASDAQ: NVCR ) reached a 52-week low on Tuesday after the medical device maker and its China-based partner Zai Lab ( ZLAB ) posted late-stage data for their cancer treatment device, Tumor Treating Fields (TTFields), in patients...

ZLAB - Novocure, Zai Lab post Phase 3 data for electric fields device in lung cancer

2023-06-06 09:02:06 ET NovoCure ( NASDAQ: NVCR ) lost ~10% while Zai Lab Limited ( ZLAB ) shed ~1% in the premarket Tuesday after the companies shared late-stage data for their cancer treatment device, Tumor Treating Fields (TTFields), in patients with lung cancer. A...

ZLAB - Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies

Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpo...

ZLAB - Zai Lab to Highlight New Data from its Oncology Pipeline at 2023 ASCO Annual Meeting

Three poster presentations to provide updates on Zai Lab’s oncology programs focused on unresectable solid tumors, ovarian cancer and gastrointestinal stromal tumors Early Phase 1/2 study data from Zai Lab’s internally developed ZL-1211 program support a solid safety/toler...

ZLAB - Marker, Nano-X top healthcare gainers, Belite, Phio among losers

2023-05-31 10:05:20 ET Gainers: Marker Therapeutics ( MRKR ) +34% . Nano-X Imaging ( NNOX ) +13% . Zai Lab ( ZLAB ) +9% . Invivyd ( IVVD ) +8% . Corbus Pharmaceuticals ( CRBP ) +7% . Losers: Belite Bio ( BLTE ) ...

ZLAB - TRVN, ZLAB and BRFS are among pre market gainers

2023-05-31 08:20:18 ET WANG & LEE GROUP ( WLGS ) +45% . Marker Therapeutics ( MRKR ) +37% Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma Cells. LL Flooring Holdings ( LL ) +20% jumps after founder offers...

ZLAB - Zai Lab Announces Participation in June Investor Conferences

SHANGHAI, China and CAMBRIDGE, Mass., May 25, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the company’s senior management team will participate in the following investor conferences in June 2023: Jefferies Global Healthcare Co...

ZLAB - Why Shares of Alibaba, PDD, and Zai Lab Are Rising Today

2023-05-22 11:11:09 ET Shares of several Chinese stocks moved higher today on Wall Street bullishness and after more positive comments made by President Joe Biden recently on U.S.-China relations. Shares of the large tech conglomerate Alibaba Group (NYSE: BABA) traded more than ...

ZLAB - Zai Lab gets priority review for lung cancer dug repotrectinib in China

2023-05-18 08:50:29 ET China's National Medical Products Administration (NMPA) granted priority review to Zai Lab's ( NASDAQ: ZLAB ) repotrectinib to treat adult patients with locally advanced or metastatic ROS1-positive non-small-cell lung cancer (NSCLC). A priority...

Previous 10 Next 10